Arterial endothelial permeability and vascular disease. The "trap door" effect.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000473:pathology / Q000503:physiopathology; D001158:Arteries / Q000503:physiopathology*; D001161:Arteriosclerosis / Q000209:etiology; D001792:Blood Platelets; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects; D004727:Endothelium; D005260:Female; D007365:Intercellular Junctions; D008074:Lipoproteins / Q000378:metabolism; D046911:Macromolecular Substances; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013927:Thrombosis / Q000209:etiology; D014652:Vascular Diseases / Q000209:etiology* / Q000503:physiopathology
D008074:Lipoproteins; D046911:Macromolecular Substances; D000804:Angiotensin II; D012701:Serotonin; D001920:Bradykinin; D009638:Norepinephrine